DOW JONES21,917.16-410.32 -1.84%
S&P 5002,584.59-42.06 -1.60%
NASDAQ7,700.10-74.05 -0.95%
 News
Kala Pharmaceuticals Looks To Keep Rally Going
Seeking Alpha - Article · 18h ago
Insiders Who Bought The Crash, What It Means For Returns, And My Favorite Pick
Seeking Alpha - Article · 5d ago
Kala's Upcoming NDA Submission For EYSUVIS Is A Great Catalyst Opportunity
Seeking Alpha - Article · 03/24 15:29
13D Filings
Barrons.com · 03/21 01:30
Daily Insider Ratings Round-Up 3/16/20
Seeking Alpha - Article · 03/18 16:54
HC Wainwright & Co. Maintains Buy on Kala Pharmaceuticals, Raises Price Target to $13
Benzinga · 03/18 11:10
Daily Insider Ratings Round Up 3/13/20
Seeking Alpha - Article · 03/17 17:42
Insiders Roundup: Masimo, Hertz
GuruFocus.com · 03/15 21:24
Biotech Stock Roundup: NVAX, CANF Up on Coronavirus Treatment Updates & More
Zacks · 03/11 16:06
Oppenheimer: These 3 Stocks Are Ripe for Double-Digit Gains
TipRanks · 03/11 15:50
Kala pharmaceuticals up 16% premarket after pricing stock offering
seekingalpha · 03/11 15:47
INO, DXC among premarket gainers
Seeking Alpha - Article · 03/11 13:16
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
Benzinga · 03/11 12:05
26 Stocks Moving in Wednesday's Pre-Market Session
Benzinga · 03/11 11:54
Kala Pharmaceuticals On March 10, Notified Jefferies It Was Suspending,Terminating Prospectus Related To Sales Agreement Entered Into On Aug 9, 2018; Will Not Make Any Sales Of Common Stock Pursuant To Sales Agreement Unless A New Prospectus Is Filed
Reuters · 03/11 10:21
Kala Pharmaceuticals 16M Share Offering of Common Stock @$7.89/Share
Benzinga · 03/11 09:17
Kala Pharma launches equity offering; shares down 2% after hours
seekingalpha · 03/11 01:55
Kala Pharmaceuticals Announces Proposed Public Offering of Common Stock
Business Wire · 03/10 21:44
Hearing Kala Pharma Shares Expected To Be Offered At $7.50/Share
Bloomberg · 03/10 20:56
Kala Pharma Reports $100M Common Stock Offering
Benzinga · 03/10 20:45